TY  - JOUR

T1  - Phase III trial of oral ibandronate and intravenous zoledronic acid in breast cancer patients with bone metastases: comparison of bone turnover markers

JO  - EJC SUPPL

PY  - 2005/10/01

AU  - Lichinitser M

AU  - Coleman RE

AU  - Tjulandin SA

AU  - Bergstrom B

AU  - Body JJ

ED  - 

VL  - 3

IS  - 2

SP  - 113

EP  - 113

Y2  - 2025/10/10

ER  -